OMDA · Omada Health, Inc.

Track OMDA — free

$20.41 -0.40 (-1.92%) At close · Oct 1

Russell 2000 member Rebalance outlook locked

Market Cap

$1.20B

61.22M

Volume · Oct 1 1.44M Avg daily vol (3M) 1.4M

Up next

Next earnings call

Nov 5, 2026 Est · unconfirmed · in 5 wks

Latest filing: 10-Q

filed Aug 7, 2026

Q2 2026 earnings call transcript

call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$309.76M

Trailing 12 months

Net income (TTM)

$4.30M

Trailing 12 months

Revenue growth YoY

+43.1%

Year over year

Operating margin

-0.1%

Trailing 12 months

P / E (TTM)

19.4

Trailing earnings · reciprocal yield 5.1%

FCF yield

1.9%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+191.1%

Year over year · more shares

Price change (1Y)

-5.9%

Trailing year

Short interest

12.2%

Latest settlement · 5.9 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 16.4 · calm Equity put/call 0.57

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +18%

above

Price vs 50-day avg −6%

below

RSI (14) 46

neutral

MACD trend Positive

52-week position 60%

mid-range

Momentum

relative strength

Strong

1-month return −12%

trailing

6-month return +79%

trailing

YTD return +29%

this year

Relative strength +66%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $22 › 200d $17 — 50d above 200d

Institutional flow Accumulating

+9% holders QoQ · +34 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

12.20% of float · ▲ +30.1% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

153 holders — near 1-yr high, broad support

Squeeze score 73

high risk · 0–100

Fundamentals

Excellent

Revenue growth +53%

Y/Y

Gross margin 66%

expanding

EPS growth +94%

Y/Y

Free cash flow $16.9M

Balance sheet $222.0M

net cash

Quant / Vol

risk profile

Very High

Volatility 60%

annualized · 1-yr

Max drawdown −59%

past year

ATR 5.1%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 6, 2026

Revenue · year ending December 31, 2026 Initiated $334M – $340M

prior FY $260.21M midpoint +29.5% Y/Y

Adjusted EBITDA · year ending December 31, 2026 Non-GAAP Initiated $21M – $27M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+18% Bullish

Price vs 50-day avg

−6% Bearish

RSI (14)

46 Neutral

MACD trend

Positive Bullish

52-week position

60% Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $22 › 200d $17 — 50d above 200d

Institutional flow Accumulating

+9% holders QoQ · +34 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

12.20% of float · ▲ +30.1% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

153 holders — near 1-yr high, broad support

Price context

position in its 52-week range

Range low $11 Now $20 · 60% Range high $27

vs 200-day avg +18% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
OMDA Omada Health, Inc. this stock	$1.20B	+29.3%	+53.2%	—	12.2%
VEEV Veeva Systems Inc	$45.44B	+26.3%	+28.1%	45.9	3.1%
TEM Tempus AI, Inc.	$15.34B	+29.6%	+83.4%	—	15.6%
PMDIY Pro Medicus Ltd./ADR	$12.20B	-29.7%	—	—	0.0%
BTSG BrightSpring Health Services, Inc.	$11.02B	+52.9%	+28.2%	33.8	5.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

153

% held: 89.6%
Net QoQ: +5.4M sh
Top holder: Revelation Capital Manage…

Held Float

View

Held by Funds

Fund positions

127

View

Short & Settlement

Short Interest Rising

Shares short

7.5M

Days to cover: 5.9d
Change: +1.7M sh

View

Short Volume

Short vol %

63%

As of: Oct 1, 2026

Short Total

View

Fails to Deliver

FTD shares

24.8K

Value: $563.7K
As of: Sep 8, 2026

View

Off-Exchange

Off-exchange %

36.5%

Week of: Aug 24, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$260.2M

Net income (FY): $-12.8M
EPS diluted: $-0.35

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Sep 10, 2026
This year: 12

View

Proposed Sales

Value

$321.6K

Shares: 15.0K
Filed: Sep 10, 2026

View

Earnings & Events

Webcasts

Last webcast

Sep 10, 2026

View

Performance

	5D	20D	120D	MTD	YTD
OMDA	+3.5%	-12.4%	+78.9%	-1.9%	+29.3%
SPY	-0.4%	-0.2%	+12.4%	+0.2%	+12.0%
vs SPY	+3.9%	-12.3%	+66.4%	-2.1%	+17.3%

Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 3 filings 3 filers Visit website Investor relations

OMDA · Omada Health, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance